1. LBA35TROPHIMMUN, a 2 cohort phase II trial of the anti-PD-L1 monoclonal antibody avelumab in chemo-resistant gestational trophoblastic neoplasia (GTN) patients: Preliminary outcomes in cohort A. (23rd October 2018) Authors: You, B M; Bolze, P A; Lotz, J -P; Massardier, J; Gladieff, L; Hajri, T; Maucort-Boulch, D; Bin, S; Roux, A; Rousset, P; Freyer, G; Golfier, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗